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1078–5Objectives. The aim of the present study was to estimate the need for late lower limb revascularization and/or major
amputation after coronary artery bypass grafting (CABG).
Design. Retrospective study.
Patients and methods. 1307 residents of Oulu who underwent CABG from 1990 to 2006 formed the basis of this
community-wide study.
Results. During a mean follow-up of 7.1 4.5 years, 111 patients (8.5%) underwent 251 vascular procedures for lower
limb ischemia and 25 major amputations. In four patients, revascularization was done for complicated wound after vein
graft harvesting. Freedom rates from lower limb revascularization and/or major amputation at 5-, 10- and 15-year were
92.9%, 88.4% and 85.1%, whereas freedom rates from lower limb revascularization for critical ischemia and/or major
amputation were 98.1%, 95.2% and 94.7%. Age (p¼ 0.013, HR 1.05), extracardiac arteriopathy (p< 0.0001, HR
5.39), left ventricular ejection fraction classes (p¼ 0.03), diabetes (p< 0.0001, HR 5.78), and estimated glomerular fil-
tration rate<60 mg/min/m2 (p¼ 0.02, HR 2.22) were independent predictors of lower limb revascularization for critical
leg ischemia and/or major amputation.
Conclusions. Patients with extracardiac arteriopathy, diabetes and decreased glomerular filtration rate at the time of
CABG are at risk for late lower limb ischemia. These patients would most benefit of a closer follow-up for prevention of
peripheral vascular disease and its related complications.
 2007 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Coronary artery disease requiring coronary artery
bypass surgery (CABG) is one of the most severe compli-
cations of atherosclerosis. In these patients, peripheral
arterial disease is a formidable risk factor for immedi-
ate postoperative mortality.1e3 Indeed, peripheral
arterial disease has been shown to be an important
predictor also of long-term outcome after CABG.4,5
This is not a surprise as peripheral arterial disease
in the general population has been widely shown to
be associated with increased risk of cardiovascular
and overall mortality.6 There is also evidence on the
adverse impact of decreased ankle-brachial index7,8
as well as of incompressible ankle arteries7 on thesponding author. F. Biancari, MD, PhD, Division of Cardio-
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884/000596 + 07 $34.00/0  2007 European Society for Vasculalong-term outcome of patients undergoing coronary
revascularization. The other way round, there is no
data on the occurrence of severe lower limb ischemia
after CABG. Herein, we attempted to estimate its inci-
dence by assessing the need of lower limb revascular-
ization and/or major amputation after CABG in
a community-wide study.Material and Methods
This study included a series of 1307_residents of the
city of Oulu and who were referred for isolated
CABG to the Division of Cardio-thoracic and Vascu-
lar Surgery of the Oulu University Hospital, Oulu,
Finland, from January 1990 to December 2006. This
series belongs to a consecutive series of 1397 patients
who underwent isolated CABG at our institution
and who were residents of the city of Oulu. We
have removed from this series those patients who
at the time of death or data collection were notr Surgery. Published by Elsevier Ltd. All rights reserved.
597Lower Limb Ischemia Late after CABGresiding anymore in the Oulu area. A few patients
without preoperative data on left ventricular ejection
fraction and serum creatinine were excluded as well.
Patients undergoing procedures other than CABG
have been excluded as their outcome is likely to be
different from those undergoing isolated CABG, i.e.
patients with associated valve heart disease, and in
several cases having less severe coronary artery
disease.
Our Institution is a tertiary referral university
hospital for cardiac-thoracic and vascular surgery
and serves 49.5% of Finland’s surface where reside
about 723 000 inhabitants. No other public or private
vascular surgery service exists in the Oulu area. Also
all minor and major lower limb amputations are per-
formed at our Institution.
Data have been collected retrospectively from
patients’ records including files of all departments of
our hospital. Risk factors have been defined according
to the EuroSCORE criteria.3 According to this scoring
risk method, extracardiac arteriopathy denotes any
one or more of the following: claudication, carotid oc-
clusion or >50% stenosis, previous or planned inter-
vention on the abdominal aorta,limb arteries or
carotids. Previous lower limb revascularization refers
to any surgical and/or endovascular revasculariza-
tion procedure performed on the aortoiliac arterial
segment and/or infrainguinal arteries for lower limb
ischemia. Preoperative glomerular filtration rate was
estimated and classified according to the modified
Modification of Diet in Renal Disease study
equation:9e11
Patients’ characteristics and operative data at the
time of CABG are reported in Table 1. Data on late
death have been retrieved from a National Registry
(Tilastokeskus).Statistical analysis
Statistical analysis was performed using a SPSS statis-
tical software (SPSS v. 14.0.1, SPSS Inc., Chicago, Ill.,
USA). Continuous variables are reported the mean
standard deviation. Survival rates were estimated
by the Kaplan-Meier’s method. Univariate analysis
was performed with the Kaplan-Meier’s test and
with the Cox regression analysis. Cox-regression
with the help of backward stepwise method was
used for multivariate analysis, and hazard ratios
(HRs) and 95% confidence intervals (95%CIs) were
calculated. Only variables with a p< 0.2 at univariate
analysis have been included into the regression
model. A p< 0.05 was considered statistically
significant.Results
Survival
Twenty eight patients (2.1%) died during the 30-day
postoperative period. The mean follow-up period
was 7.1 4.5 years (median 6.8 years, range 0e17.0
years). The survival rates at 5-, 10-, and 15-year
follow-up were 89.0%, 72.3%, and 55.1%, respectively.
Causes of late death among operative survivors are
summarized in Table 2.Need for lower limb revascularization and/or major
amputation after CABG
During the follow-up, 111 patients (8.5%) underwent
251 vascular procedures on the lower extremities
and 25 major amputations, three having been re-
amputations. These procedures have been performed
on both lower limbs in 45 (41%) patients. Intermittent
claudication was the indication for intervention in 165
cases, critical leg ischemia in 106 cases, anastomotic
pseudoaneurysm in 3 cases, and graft infection in 2
cases. The latter procedures have been included in
the analysis as occurred as complication of previous
revascularization procedures done for lower limb
ischemia. Indeed, these did not have any impact on
the freedom rates from lower limb revascularization.
In four patients (3.6%), revascularization was indi-
cated by the presence of complicated wound after
vein graft harvesting which were not amenable to
conservative treatment. Among 29 patients (2.2%)
who had inserted pre- or postoperatively an intra-aortic
balloon pump, one patient underwent a below-
the-knee amputation on the 3rd postoperative day
and died on the same day. Neither lower limb re-
vascularization nor major amputation have been per-
formed in the other patients with intra-aortic balloon
pump during the follow-up. Data on the type of vas-
cular/endovascular procedures performed as well as
on major amputations of the lower limb are summa-
rized in Table 3.
During the study period, the freedom rate from any
lower limb revascularization and/or major amputa-
tion at 5-year was 92.9% at 10-year 88.4%, and at
15-year 85.1%.
The freedom rate from any lower limb revasculari-
zation for critical ischemia and/or major amputation
was at 5-year was 98.1%, at 10-year 95.2%, and at
15-year 94.7%. Leg salvage rate in the overall popula-
tion at 5-year was 99.2%, at 10-year 97.8%, and at
15-year 97.3%.Eur J Vasc Endovasc Surg Vol 35, May 2008
Table 1. Clinical and operative risk factors in 1307 patients who underwent CABG. P-values refer to association between risk factors
and the outcome end-points at univariate analysis
Risk factors Any lower limb
revascularization and/or
major amputation
Any intervention
for critical leg
ischemia
Lower limb
major
amputation
p-value p-value p-value
Age (years) 64.2 9.5 0.002 <0.0001 0.011
Females 346 (26.5) 0.23 0.89 0.35
Previous cardiac surgery 36 (2.8) 0.31 0.93 0.52
Previous CABG 30 (2.8) 0.24 0.89 0.53
Previous PCI 138 (10.6) 0.15 0.25 0.15
Pulmonary disease 77 (5.9) 0.18 0.19 0.28
LVEF> 50% 1085 (83.0) 0.03 0.08 0.16
30e49% 176 (13.5)
<30% 46 (3.5)
Systolic PAP> 60 mmHg 16 (1.2) 0.31 0.54 0.69
Critical preoperative status 51 (3.9) 0.25 0.16 0.23
Preoperative IABP 7 (0.5) 0.58 0.76 0.84
Atrial fibrillation 81 (6.2) 0.09 0.98 0.92
Unstable angina 212 (16.2) 0.95 0.49 0.71
Extracardiac arteriopathy 191 (14.6) <0.0001 <0.0001 <0.0001
Previous peripheral vascular/
endovascular surgery
119 (9.1) <0.0001 <0.0001 <0.0001
Previous lower limb revascularization 68 (5.2) <0.0001 <0.0001 <0.0001
Claudication 67 (5.1) <0.0001 <0.0001 <0.0001
Carotid artery disease 66 (5.0) <0.0001 0.019 0.21
Planned vascular operation 23 (1.8) <0.0001 0.096 0.58
Diabetes 275 (21.0) <0.0001 <0.0001 <0.0001
Hypertension 599 (45.8) 0.07 0.02 0.009
Neurological dysfunction 26 (2.0) 0.43 0.77 0.24
Transient ischemic attack 70 (5.4) 0.01 0.03 0.24
Stroke 92 (7.0) 0.004 <0.0001 0.03
Myocardial infarction< 3 months 367 (28.1) 0.65 0.73 0.94
Operation 0.85 0.86 0.62
Elective 759 (58.1)
Urgent 507 (38.8)
Emergent 41 (3.1)
At least one mammary a. graft 1187 (90.8) 0.28 0.12 0.002
No. distal anastomoses 4.1 1.1 0.05 0.06 0.02
OPCAB 194 (14.8) 0.63 0.70 0.97
Additive EuroSCORE 3.7 3.1 <0.0001 <0.0001 <0.0001
CKD classes 0.01 <0.0001 0.001
Class 1 309 (23.6)
Class 2 803 (61.4)
Class 3 186 (14.2)
Class 4 6 (0.5)
Class 5 3 (0.2)
Variables are according to the EuroSCORE criteria;3 CABG: coronary artery bypass grafting; PCI: percutaneous transluminal intervention;
LVEF: left ventricular ejection fraction; PAP: pulmonary artery pressure; IABP: intra-aortic balloon pump; OPCAB: off-pump coronary
artery bypass surgery; CKD: Chronic Kidney Disease classification.10
598 F. Biancari et al.Variables significantly associated at univariate
analysis with any of these late outcome end-points
are listed in Table 1.
At multivariate analysis, extracardiac arteriopathy
( p< 0.0001, HR 6.56, 95%CI 4.38-9.84), diabetes
( p< 0.0001, HR 2.32, 95%CI 1.58-3.42) and additive
EuroSCORE ( p¼ 0.047, HR 1.08, 95%CI 1.00-1.56)
were independent predictors of any late lower limb
revascularization and/or major amputation.
Patient’s age ( p¼ 0.013, HR 1.05, 95%CI 1.00-1.09),
extracardiac arteriopathy ( p< 0.0001, HR 5.39, 95%CI
2.86-10.14, Fig. 1), left ventricular ejection fraction
classes ( p¼ 0.03), diabetes ( p< 0.0001, HR 5.78,Eur J Vasc Endovasc Surg Vol 35, May 200895%CI 3.07-10.87, Fig. 2), and eGFR< 60 mg/min/
m2 ( p¼ 0.02, HR 2.22, 95%CI 1.13-4.33, Fig. 3) were
independent predictors of any late lower limb revas-
cularization for critical leg ischemia and/or major
amputation.
Extracardiac arteriopathy ( p¼ 0.039, HR 3.74, 95%CI
1.07-13.03), diabetes ( p¼ 0.006, HR 3.84, 95%CI 1.48-
10.02), eGFR< 60 mg/min/m2 ( p¼ 0.005, HR 3.96,
95%CI 1.52-10.32), previous lower limb revasculariza-
tion ( p¼ 0.030, HR 4.00, 95%CI 1.14-14.07) and no
mammary artery graft used ( p¼ 0.032, HR 0.30,
95%CI 0.10-0.90) were independent predictors of late
major lower limb amputation.
Table 2. Causes of late death after coronary artery bypass surgery
among operative survivors
Ischemic heart disease 119
Stroke 17
Intracranial haemorrhage 16
Aortic dissection or aneurysm rupture 4
Congestive heart failure 3
Degenerative neurological diseases 7
Malignancies
Brain 1
Breast 2
Esophagus 2
Eye 1
Stomach 4
Hodgkin disease 1
Liver 3
Lung 15
Pancreas 10
Peritoneum 1
Prostate 12
Rectum 3
Kidney 2
Skin 1
Urinary bladder 2
Unspecified site 3
Respiratory failure 6
Gastrointestinal bleeding 5
Diabetes complications 2
Intoxication 2
Cirrhosis 1
Unspecified metabolic disease 2
Pancreatitis 1
Pneumonia 1
Suicide 2
Trauma 7
Table 3. Vascular and endovascular interventions for lower limb
ischemia performed in 111 patients after coronary artery bypass
surgery
Type of procedure No.
Endovascular procedures
Endovascular intervention on the iliac arteries 25
Endovascular intervention on the common femoral artery 4
Endovascular intervention on the profunda femoris 2
Endovascular intervention on the superficial femoral artery 58
Endovascular intervention on the popliteal artery 13
Endovascular intervention on the infrapopliteal arteries 15
Endovascular intervention on multilevel arteries 44
Sugical procedures
Aortobifemoral bypass 3
Iliaco-femoral bypass 1
Femoro-femoral crossover bypass 2
Endarterectomy of the common femoral artery and its
branches
10
Popliteo-infrapopliteal bypass 1
Femoropopliteal bypass 27
Redo femoropopliteal bypass 6
Femoroinfrapopliteal bypass 7
Redo femoroinfrapopliteal bypass 1
Thrombectomy and/or surgical revision of anastomoses
of previous bypass grafts
25
Thromboembolectomy of native arteries 3
Other surgical procedures 4
Above-the-knee amputation* 8
Below-the-knee amputation* 17
* Among major lower limb amputations there are 3 major
re-amputations.
599Lower Limb Ischemia Late after CABGOutcome after lower limb revascularization and/or
major amputation
The overall 5- and 10-year survival rates of these 111
patients after any first lower limb revascularization
procedure and/or major amputation were 72.1%
and 33.0%. The 30-day postoperative mortality rate
after the first lower limb revascularization procedure
or major amputation was 2.7%. These two patients
died of myocardial infarction a few days after
below-the-knee amputation.
The overall 5- and 10-year survival rates of 41 pa-
tients after their first lower limb revascularization
procedure for critical ischemia and/or major amputa-
tion were 53.2% and 21.4%. The 30-day postoperative
mortality rate among these patients with critical lower
limb ischemia was 12.2%. All these patients died of
ischemic heart disease.Discussion
To our knowledge, CASS Investigators are the only
who have so far reported on the amount of vascular
surgery procedures performed in patients after
CABG.12 They reported on 175 vascular proceduresperformed during a follow-up of 4.1 years, but they
did not report on the indication for surgery. Indeed,
their analysis was focused on the operative risk of un-
dergoing noncardiac surgery among patients who had
medical therapy or have undergone CABG. Thus, no
data exists regarding the need for vascular/endovas-
cular surgery or major amputation after coronary
artery surgery.
In this community-wide study we have observed at
15 years a freedom rate from any lower limb revascu-
larization and/or major amputation of 85%, and
a freedom from critical lower limb ischemia requiring
surgical/endovascular treatment of about 95%. These
observations suggest that only a few patients under-
going CABG are expected to suffer severe lower
limb ischemia. This is a quite surprising finding in
such a patient population having severe coronary
artery disease. These are the ones expected to be
most at risk for generalized atherosclerosis.
The lack of a control group represents a major
limitation of this study. However, it is rather difficult
to identify a control group for a comparative analysis.
Indeed, most of these patients had a severe, diffuse
coronary artery disease as suggested by the mean 4.1
distal anastomoses performed in this series. Thus,
these patients are not comparable to the vast majority
of patients undergoing percutaneous coronary inter-
vention, particularly for those treated during theEur J Vasc Endovasc Surg Vol 35, May 2008
Years after coronary artery bypass surgery
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No extracardiac arteriopathy
Extracardiac arteriopathy
p<0.0001
Patients at risk 
No extracardiac arteriopathy 1116 680 325 59 
Extracardiac arteriopathy 191 117 49 4 
Fig. 1. Kaplan-Meier estimate of freedom rate from lower limb revascularization for critical limb ischemia or major
amputation among patients with and without extracardiac arteriopathy at the time of CABG.
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was associated at univariate analysis with the risk of
late lower limb revascularization and major amputa-
tion. Similarly, it would have been rather difficult toYears after coron
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Patients at risk 
No diabetes 1032 636 
Diabetes 275 161 
Fig. 2. Kaplan-Meier estimate of freedom rate from lower
amputation among patients with and without diabetes at the
Eur J Vasc Endovasc Surg Vol 35, May 2008compare these patients with other patients without
coronary artery disease or with those with coronary
artery disease under medical treatment. Thus, this
study gives an estimation of the risk to develop severeary artery bypass surgery
151413121110987
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Diabetes
320 56 
54 7 
limb revascularization for critical limb ischemia or major
time of CABG.
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Fig. 3. Kaplan-Meier estimate of freedom rate from lower limb revascularization for critical limb ischemia or major
amputation among patients with and without decreased estimated glomerular filtration rate (eGFR) at the time of CABG.
601Lower Limb Ischemia Late after CABGlower limb ischemia only in those patents with severe
coronary artery disease.
Despite the low risk to develop lower limb ischemia,
the amount of procedures performed for leg salvage
in these patients is rather relevant. Beside the in-
creased economic burden associated with these
procedures, the latter are performed not without
complications. In fact, we have estimated that the
30-day mortality rate after any first lower limb revas-
cularization procedure and/or major amputation was
about 2%, whereas it was 12% among patients under-
going revascularization for critical lower limb ische-
mia. This means that not necessarily a previously
done CABG protects the patients from adverse out-
come after lower limb revascularization. Indeed the
association of severe coronary disease treated with
CABG and the subsequent development of critical
limb ischemia should be viewed as a condition pos-
ing the patient at high risk for postoperative adverse
outcome.
The results of this study indicate that the risk to
develop lower limb ischemia seems to be greatly in-
creased among patients with coexistent extracardiac
arteriopathy and diabetes at the time of CABG. This
certainly is not a surprising finding, but along with
decreased eGFR, are indicators for a closer follow-
up of these patients, which is likely to improve also
their expectancy of life. In fact, it has been shownthat late referral to a nephrologist of patients with
pre-end stage renal disease is associated with poor
long-term outcome.13,14 This further suggests that
a strict follow-up of these patients and aggressive
treatment of their comorbidities is highly indicated.
In conclusion, at 15-year lower limb revasculariza-
tion and/or major amputation was required in 15% of
patients who underwent CABG. Patients with extrac-
ardiac arteriopathy, decreased glomerular filtration
rate and diabetes at the time of CABG are the ones
most at risk for late lower limb ischemia. These pa-
tients would most benefit of a closer follow-up for
prevention of peripheral vascular disease and its
related complications.References
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